| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701292 | European Journal of Surgical Oncology (EJSO) | 2017 | 8 Pages |
Abstract
In Responders, TME or e-TME are technically and oncollogically feasible and should be considered in preferrence to b-TME. In Non-responders, allowing for high rates of morbidity and local recurrence in patients with e-TME, b-TME procedures should be preferred.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Q. Denost, C. Kontovounisios, S. Rasheed, R. Chevalier, R. Brasio, M. Capdepont, E. Rullier, P.P. Tekkis,